What Nitinol Devices & Components does

Confluent Medical Technologies, formerly Nitinol Devices & Components (NDC), is a privately held, vertically integrated contract manufacturer specializing in medical-grade Nitinol (nickel-titanium alloy) materials and components. Founded in 1991 by Tom Duerig to pioneer the use of Nitinol in medical devices, the company was acquired by Cordis (Johnson & Johnson) in 1994, regained independence in 1998, and rebranded to Confluent Medical Technologies in 2013 as it broadened its capabilities beyond Nitinol components into a broader medical device manufacturing platform.

The company operates an end-to-end production chain spanning Nitinol melt (through its 2024 fulfillment partnership with ATI, adding over 300% melt capacity), mill products (tubing, wire, hollows, including the proprietary SE 508 ELI extra-low-interstitial high-purity grade introduced in 2008), and finished components such as laser-cut stents, frames, wireform devices, complex catheters, balloon catheters, sheaths and dilators, polymer stent coverings, biomedical textiles, and precision extrusion. Manufacturing is conducted across four locations — Fremont, CA (components and tube drawing), Windham, ME (gun drilling), Costa Rica (large-scale manufacturing since 2010), and India (wire manufacturing since 2022) — with cumulative capital investment exceeding $125M and committed lead times of 10–14 weeks for tubing and 20 weeks for wire. Technical differentiators include short pulse laser processing (since 2012), large diameter tube drawing, rapid prototyping, and the 2017 High-Performance Nitinol Tubing Center of Excellence.

Confluent generates revenue through quote-based B2B contract manufacturing and direct OEM sales to medical device manufacturers, with no publicly disclosed pricing. Its primary customer base is Medical Device OEMs building cardiovascular and endovascular products (stents, catheter components, implantable devices), served through a direct enterprise sales motion supported by technical education platforms (Nitinol University, Textile University), industry events, and digital content channels. The company holds 501–1,000 employees and is headquartered in Fremont, California, with a 2011 growth investment from Ampersand Capital Partners and no disclosed parent company or public listing.

Name

Nitinol Devices & Components

Legal name

Confluent Medical Technologies

Website

https://nitinol.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Confluent Medical Technologies (formerly Nitinol Devices & Components) is a vertically integrated contract manufacturer of medical-grade Nitinol materials and components — including tubing, wire, stents, and catheters — serving medical device OEMs globally from facilities in the US, Costa Rica, and India.

Ownership category

akta.pro rank

Product category

Medical Device Contract Manufacturing

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Plastics Products, Nec (3089)

akta.pro primary industry

Medical Devices & Dental (Production AM Parts) (IMAAAEAD)

Keywords

• Medical device contract manufacturing
• Nitinol components
• Nitinol tubing wire
• Biomedical textiles
• Catheter manufacturing

Headquarters

HQ city

Fremont

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure

Distribution channels1 record

Marketing channels5 records

Core offering

Nitinol Devices & Components (now Confluent Medical Technologies) is a vertically integrated contract manufacturer specializing in medical-grade Nitinol (Nickel-Titanium alloy) and polymer components for medical device OEMs. The company manufactures mill products, hollows, tubes, wires, finished components (stents, frames, implants), polymer tubing, biomedical textiles, and complex catheter systems for medical, industrial, and consumer markets.

Product overview

Confluent Medical Technologies (formerly Nitinol Devices & Components/NDC) operates as a vertically integrated contract manufacturer specializing in medical-grade Nitinol and polymer components. The company offers a unified manufacturing platform spanning the entire supply chain from melt production through finished components: mill products (Nitinol Tubing and Wire), fabricated components (Nitinol Components/Frames), and catheter systems (Complex Catheters, Balloon Catheters, Catheter Components). Supporting capabilities include Biomedical Textiles, Polymer Tubing, Polymer Stent Coverings, and Extrusion services. Manufacturing is supported by Design & Testing, Rapid Prototyping, Laser Cutting and Welding, and Nitinol Device Processing modules. Key materials include proprietary SE 508 ELI (Extremely Low Inclusion) high-purity Nitinol introduced in 2008. The company maintains manufacturing facilities in Fremont CA, Windham ME, Costa Rica, and India, with lead times of 10-14 weeks for tubing and 20 weeks for wire.

Differentiator

Problem solved

Functional benefit

Products and services

• Nitinol Components (Frames) Contract manufacturing services for Nitinol wireform devices and laser-cut designs including stents, frames, and complex medical implants for medical device OEMs.
• Nitinol Tubing and Wire Vertically integrated Nitinol mill products including precision tubing, wire, and hollows for medical device manufacturing. Lead times of 10-14 weeks for tubing and 20 weeks for wire.
• Polymer Tubing

Quantifiable outcome

• 300%+ increase in Nitinol melt capacity
• +2 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• ATI (Allegheny Technologies Incorporated)coreStrategic or Co-development Partner · 1 January 2024Confluent Medical Technologies invested over $50M in Nitinol Melt expansion and became a fulfillment provider for Medical Nitinol with ATI. This partnership enables Confluent to provide the most secure and vertically integrated Nitinol supply chain, increasing melt capacity over 300%. The relationship positions Confluent as a fulfillment partner for ATI's medical-grade nitinol materials.

Scale indicators7 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• Fort Wayne Metals: Fort Wayne Metals is a leading manufacturer of precision medical wire, including nitinol wire and cable for medical devices. It is one of the closest direct competitors to Confluent in nitinol materials for medical applications, competing particularly in wire and component tiers.
• Integer Holdings: Integer Holdings is a large medical device contract manufacturer offering components and assemblies to OEMs across cardiovascular, neurovascular, and other therapy areas. It is a comparable B2B medical contract manufacturer to Confluent's catheter and component business, with overlapping customer profiles.
• Heraeus Medical Components: Heraeus Medical Components manufactures specialized components for medical devices including nitinol-based components and assemblies. As part of the broader Heraeus precious metals and technology group, it competes with Confluent in serving cardiovascular and endovascular OEMs with component manufacturing.
• SAES Smart Materials (Memry Corporation): SAES Group's Memry business is a direct nitinol components manufacturer serving medical device OEMs with shape-memory alloy components, including stents and frames. It is the most direct competitor to Confluent's vertically integrated nitinol device manufacturing platform.
• Tegra Medical: Tegra Medical is a precision contract manufacturer of medical devices and components, including metal and polymer fabrication. It is comparable to Confluent in offering multi-capability medical device manufacturing services to OEM customers, with overlap in machining, assembly, and finishing services.

Broad incumbents

• ATI (Allegheny Technologies): ATI is a specialty materials producer with a significant nitinol and titanium alloy business and serves as Confluent's strategic upstream partner for medical-grade nitinol melt. While also a supplier/partner, ATI represents a broader incumbent in specialty alloys that could expand into downstream tiers.
• Johnson Matthey: Johnson Matthey is a global specialty chemicals and advanced materials company with significant presence in precious metals, catalysts, and medical materials including nitinol. It is a broader incumbent that overlaps with Confluent in specialty alloys for medical applications but operates across many other industries.
• Boston Scientific: Boston Scientific is a major medical device OEM and significant consumer of nitinol components across its cardiovascular, peripheral intervention, and endoscopy franchises. While primarily a customer for Confluent rather than a direct competitor, it represents the broader medical device landscape where nitinol components are deployed at scale.
• Abbott (Cardiovascular): Abbott's cardiovascular and structural heart franchises (including the legacy St. Jude Medical portfolio) are major consumers of nitinol components for stents, occlusion devices, and closure systems. Comparable to Confluent's OEM customer base, it operates as a broad incumbent medical device company that drives demand for nitinol contract manufacturing.

Emerging players

• Resonetics: Resonetics is a specialized contract manufacturer focused on laser micromachining and nitinol processing for medical devices, including stents and catheter components. It is an emerging specialist with significant capability overlap in laser-cut nitinol components but at smaller scale than Confluent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks2 records

Key highlights7 records

Customer concentration

• Xx.com/ConfluentMed
• YouTubeyoutube.com/channel/UCGf8CQnvV3ainxkKneTaP6A
• Facebookfacebook.com/ConfluentMedical
• LinkedInlinkedin.com/company/confluent-medical-technologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nitinol Devices & Components